Homocysteine is considered to be an independent risk factor for atherosclerosis.
Introduction
Hyperhomocysteinemia is considered to be a risk factor for thromboembolic disease. Several studies have shown that this biochemical abnormality is associated with atherosclerotic vascular disease (1) . However, results of recent prospective studies are contradictory, and raise the question of whether homocysteine itself may cause thromboembolic disease (2) . Models of hyperhomocysteinemia-induced atherosclerosis have been developed in rabbits and minipigs by feeding high doses of methionine (3, 4). Aortic lesions in these animals showed thickening of intima, fragmentation of the elastic laminae, the deposition of cholesterol and the presence of calcification.
Of those, the presence of aortic calcification is usually considered to indicate an advanced state of atherosclerosis (5). However, the mechanism of such calcification is not fully understood (6, 7). To elucidate the effects of homocysteine on aortic calcification, we measured the extent of calcification in the human aorta using computerized tomography(CT) (8), and determined the plasma level of homocysteine, in addition to evaluating the conventional cardiovascular risk factors. The association between the plasma level of homocysteine and the extent of aortic calcification was analyzed.
Subjects
We evaluated 28 Japanese patients (7 men and 21 women, mean age 61.8+6.7) with hyperlipidemia who Table 2 . Characteristics of groups with high and low levels of homocysteine kidney contributes to its plasma concentration (10), we expected the creatinine level to be higher in patients with hyperhomocysteinemia. Hyperparathyroidism is known to be induced by renal failure, leading to the deposition of calcium in the soft tissue (11). However the level of PTH did not differ between the groups, suggesting that the elavated creatinine level did not contribute to aortic calcification in the patients with NHL.
Atherosclerotic calcification is an organized process that resembles bone formation. Calcium deposits are commonly found in advanced atherosclerotic lesions, and calcification becomes a dominant finding in complicated atherosclerotic lesions (7). A variety of molecules are associated with bone formation, including osteocalcin, osteopontin, osteonectin and bone morphogenetic protein-2a.
These molecules have also been shown to be present in atherosclerotic lesions (12, 13). These molecules are synthesized by the smooth muscle cells, foam cells derived from the macrophage, and the pericytes that make up the vascular wall (14-16). The cytokines and growth factors found in the atherosclerotic lesions stimulate the synthesis of such molecules.
Risk factors for atherosclerotic calcification include older age, female gender, high level of cholesterol, low level of HDL cholesterol, smoking, obesity, and diabetes (6). Calcification of the artery is seen in experimental hyperhomocysteinemia (3), as well as in patients with homocysteinuria (17). However, since there are few reports of patients with arteries or aortae of with mild hyperhomocysteinemia, it is not known whether mild hyperhomocysteinemia causes the calcification of artery and aorta. The mechanism of the aortic calcification induced by homocysteine remains to be fully elucidated.
The fraying of the elastic fibers and the increased deposition of glycosaminoglycan may be associated with such calcification (17). Further study of the effects of homocysteine on the biosynthesis of osteogenesis-related proteins of osteopotin and osteocalcin, are indicated.
In summary, we report that a mildly high plasma level of homocysteine was associated with a high extent of aortic calcification in the patients in this study. This finding suggests that the interventions to reduce the plasma level of homocysteine, such as supplementation of folate, vitamin B6, may be useful in reducing the severity of arterial calcification.
